Long-term follow-up of tandem CD19/CD22 CAR T-Cells in r/r B-ALL patients with high-risk features

Wei Cui; Xin-Yue Zhang; Zheng Li; Hai-Ping Dai; Jia Yin; Qing-Ya Cui; Si-Ning Liu; Li-Qing Kang; Lei Yu; De-Pei Wu; Xiao-Wen Tang

doi:10.1002/ajh.27076

Long-term follow-up of tandem CD19/CD22 CAR T-Cells in r/r B-ALL patients with high-risk features

Am J Hematol. 2023 Nov;98(11):E338-E340. doi: 10.1002/ajh.27076. Epub 2023 Sep 4.

Authors

Wei Cui^{1

2}, Xin-Yue Zhang^{1

2}, Zheng Li^{1

2}, Hai-Ping Dai^{1

2}, Jia Yin^{1

2}, Qing-Ya Cui^{1

2}, Si-Ning Liu^{1

2}, Li-Qing Kang³, Lei Yu³, De-Pei Wu^{1

2}, Xiao-Wen Tang^{1

2}

Affiliations

¹ National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
² Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
³ Shanghai Unicar-Therapy Bio-medicine Technology Co., Ltd, Shanghai, China.

PMID: 37665759
DOI: 10.1002/ajh.27076

No abstract available

Publication types

Letter

Grants and funding

BK20201169/Natural Science Foundation of Jiangsu Province
LCZX202201/Suzhou Diagnosis and Treatment Project of Clinical Key Diseases
BCF-IBW-XY-20220930-13/Bethune Charitable Foundation
SKY2022001/Frontier Clinical Technical Project of Suzhou Science and Technology Plan
81873443/National Natural Science Foundation of China
82070162/National Natural Science Foundation of China
The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
K2019022/The Key Science Research Project of Jiangsu Commission of Health
2020ZKZC04/Translational Research Grant of NCRCH